InsidersTradesSigma
Follow the 테라젠이텍스 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 테라젠이텍스 has logged 12 reports. Market capitalisation: €72bn. The latest transaction was reported on 19 March 2026 (Purchase). Among the most active insiders: 테라젠이텍스. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
12 of 12 declarations
Teragen Etex 是一家专注于健康和制药领域的公司，在XKRX市场上市。它致力于开发生物技术领域的创新解决方案。